M
Mindy G. Schuster
Researcher at University of Pennsylvania
Publications - 52
Citations - 4068
Mindy G. Schuster is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Transplantation & Neutropenia. The author has an hindex of 22, co-authored 50 publications receiving 3848 citations.
Papers
More filters
Journal ArticleDOI
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Thomas J. Walsh,Robert W. Finberg,Carola A.S. Arndt,John W. Hiemenz,Cindy L. Schwartz,David C. Bodensteiner,Peter G. Pappas,Nita Seibel,Richard N. Greenberg,Stephen Dummer,Mindy G. Schuster,John S. Holcenberg,William E. Dismukes +12 more
TL;DR: A randomized, double-blind, multicenter trial comparing liposomal amphotericin B with conventional amphoteric in B as empirical antifungal therapy for patients with persistent fever and neutropenia.
Journal ArticleDOI
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
Thomas J. Walsh,Peter G. Pappas,Drew J. Winston,Hillard M. Lazarus,Finn Bo Petersen,John Raffalli,Saul Yanovich,Patrick J. Stiff,Richard N. Greenberg,Gerald R. Donowitz,Mindy G. Schuster,Annette C. Reboli,John R. Wingard,Carola A.S. Arndt,John F. Reinhardt,Susan Hadley,Robert W. Finberg,Michel Laverdière,John R. Perfect,Gary Garber,Giuseppe Fioritoni,Eli Anaissie,Jeanette Y. Lee +22 more
TL;DR: Voriconazole is a suitable alternative to amphotericin B preparations for empirical antifungal therapy in patients with neutropenia and persistent fever in a randomized, international, multicenter trial.
Journal ArticleDOI
Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis
John W. Baddley,John W. Baddley,David R. Andes,Kieren A. Marr,Dimitrios P. Kontoyiannis,Barbara D. Alexander,Carol A. Kauffman,Robert A. Oster,Elias Anaissie,Thomas J. Walsh,Mindy G. Schuster,John R. Wingard,Thomas F. Patterson,James I. Ito,O. Dale Williams,Tom Chiller,Peter G. Pappas +16 more
TL;DR: There are multiple variables associated with survival in transplant patients with IA and understanding these prognostic factors may assist in the development of treatment algorithms and clinical trials.
Journal ArticleDOI
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.
Benjamin J. Park,Peter G. Pappas,Kathleen Wannemuehler,Barbara D. Alexander,Elias Anaissie,David R. Andes,John W. Baddley,Janice M. Brown,Lisa Brumble,Alison G. Freifeld,Susan Hadley,Loreen A. Herwaldt,James I. Ito,Carol A. Kauffman,Carol A. Kauffman,G. Marshall Lyon,Kieren A. Marr,Kieren A. Marr,Vicki A. Morrison,Vicki A. Morrison,Genovefa A. Papanicolaou,Thomas F. Patterson,Thomas F. Patterson,Trish M. Perl,Mindy G. Schuster,Randall C. Walker,John R. Wingard,Thomas J. Walsh,Dimitrios P. Kontoyiannis +28 more
TL;DR: The incidence of mucormycosis in HCT recipients increased substantially during the surveillance period, and non-Aspergillus mold infections continue to be associated with high mortality rates.
Journal ArticleDOI
Empirical Fluconazole versus Placebo for Intensive Care Unit Patients A Randomized Trial
Mindy G. Schuster,John E. Edwards,Jack D. Sobel,Rabih O. Darouiche,Adolf W. Karchmer,Susan Hadley,Gus Slotman,Helene Panzer,Pinaki Biswas,John H. Rex +9 more
TL;DR: A recent decision-analytic model for the cost-effectiveness of empirical anticandidal therapy in high-risk ICU patients showed that empirical fluconazole would be reasonable from a cost perspective if the likelihood of invasive candida is greater than 2.5% (24).